About Us

Terpenia specializes in the vertically integrated production of medicinal cannabis full-spectrum extracts and cannabis flowers.

Building on our knowledge and with our passion for innovation we are committed to pioneering advancements in the medicinal cannabis sector, delivering precise and professional solutions for therapeutic applications.

 

Our mission

“One’s destination is never a place, but a new way of seeing things.”

Henry Miller

Terpenia’s cultivation and production facility is located in Northern Greece, within the prefecture of Serres. The region falls within the warm temperate zone (subtropics), exhibiting a Mediterranean climate marked by humid-mild winters and dry-hot summers. This climate proves to be ideal for cultivating specific strains of the cannabis plant, enabling us to grow high-quality, purely ecological cannabis.

Through a state-of-the-art extraction process, we are able to minimize the loss of volatile and fragile compounds, thereby gaining a broader spectrum of pharmacologically valuable terpenes. Our end-products are designed to feature a complex and rich palette of oils and flavors. Additionally, our extraction process minimizes the risk of biological contamination, such as fungal spores or bacteria. With a very low water activity (aw) value, our products ensure no subsequent microbial growth, eliminating the need for post-processing treatments like irradiation.

Our planned operations adhere to all pertinent European laws and regulations governing the production of pharmaceutical and herbal medicinal products. 

All of our cultivation, production, and distribution activities strictly adhere to EU regulations and good practice guidelines, ensuring compliance with industry standards.

Good Agricultural and Collecting Practice (GACP)
Good Manufacturing Practice (GMP)
Good Distribution Practice (GDP)

Sustainability: Our Promise & Values

At the core of all our operations is our environmental code of conduct, which will guide our research and production efforts and aims to consistently integrate ecological, social, and knowledge management aspects into our activities.

Sustainable Methods

Despite being significantly more labor-intensive, we prioritize traditional building and manual cultivation methods over industrial techniques. Our facility will be constructed with a careful selection of materials, including wood and glass, chosen for their minimal environmental impact. By the third year of operation, our aim is to power the facility entirely with renewables, such as solar and wind energy, contributing to our commitment to environmentally conscious practices.

Conservative use of resources

We will employ manual and individual watering techniques for our plants to minimize water consumption, avoiding the high usage associated with automated irrigation systems. Additionally, our plants will grow solely on available sunlight within our advanced glass greenhouse, eliminating the need for artificial lighting.

Ecological production

We will exclusively utilize organic fertilizers, and our extraction process will be carried out using strictly natural, non-toxic substances. We plan to closely monitor our production process to ensure that we do not emit any environmentally harmful substances.

 

%

ETHIC

We are committed to maintaining a strong dedication to carrying out all activities with consistent ethical standards. Our approach focuses on ensuring that every action we take embodies integrity, transparency, and social and environmental responsibility.

 

Job Opportunities

We aim to generate direct employment in facility administration and cultivation, along with additional seasonal positions.

Annual Investments

We plan to invest approximately one million euros annually in salaries, social security, and healthcare.

 

%

Social Engagement

We intend to allocate 5% of our profits to school projects, scholarships, and local charitable and environmental initiatives.

 

Our roadmap

“The Path is made by walking. By walking you make a path.

Antonio Machado

2021

Greece approves laws allowing the export of cannabis flowers and extracts.

 

  • Official company founding
  • Cultivation permits for medical cannabis in Greece
  • Negotiations with new investors and partners

2020

We plan our farming and production enterprise in Greece and seek new partners for research & development.

 

  • New Partners: Research agreement with the University Hospital Bonn
  • Establishing our Production Site in Alistrati – Serres
  • Full-fledged team recruit

2018

The Greek Parliament introduces law 4523/2018, authorizing the cultivation and processing of medical cannabis.

 

  • Clarification process of the legal framework for the cultivation of medical cannabis in Greece and the export for sales and research purposes within the EU

Experts

Meet Our Team

Our team consists of internationally acclaimed experts from the
fields of medicine, molecular biomedicine and botany.

Dr. rer. nat. Pavlos Kokordelis

Dr. rer. nat. Pavlos Kokordelis

CEO | Molecular Biomedicine

Dr. rer. nat. Filip Fuchs

Dr. rer. nat. Filip Fuchs

Head of Production | Molecular Botany

Maria Teresa Romano, PhD

Maria Teresa Romano, PhD

Scientific Board | Molecular Biology & Genetics

Prof. Dr. med. Jürgen K. Rockstroh

Prof. Dr. med. Jürgen K. Rockstroh

Scientific & Medical Board | Medicine

Aylar Tafazzoli, PhD

Aylar Tafazzoli, PhD

Scientific Board | Genetics

Dr. rer. nat. Wolfram Lobin

Dr. rer. nat. Wolfram Lobin

Scientific Board | Botany

Dr. phil. Maxim Egorov

Dr. phil. Maxim Egorov

Scientific Board | Psychology, People & Culture

Contact

Get In Touch

For further information about Terpenia, inquiries about our products and research methods, or for press and other collaboration requests, please get in touch with us either by using the form below or via email.

13 + 12 =

Terpenia Phytotherapeutics P.C.

 

Terpenia specializes in cultivating and producing standardized medical cannabis extracts and flowers for the Greek and other European markets.

Our primary emphasis is on the development
of finished pharmaceutical formulations.

our partners

Contact

Get In Touch

Production Facility Greece

Alistrati – Serres
PC 620 45
[email protected]

Consulting Office Germany

Dr. Pavlos Kokordelis
Breite Str. 161-167
50667 Köln
[email protected]

All rights reserved © 2021